Header Logo

Connection

Theodore Levin to Humans

Back to Details
This is a "connection" page, showing publications Theodore Levin has written about Humans.
Theodore Levin
Connection Strength
2.548
Humans
  1. Association between Improved Colorectal Screening and Racial Disparities. N Engl J Med. 2022 02 24; 386(8):796-798.
    View in: PubMed
    Score: 0.058
  2. Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details. Clin Gastroenterol Hepatol. 2021 09; 19(9):1793-1795.
    View in: PubMed
    Score: 0.055
  3. Disparities in Preventable Mortality from Colorectal Cancer: Are They the Result of Structural Racism? Gastroenterology. 2021 03; 160(4):1022-1025.
    View in: PubMed
    Score: 0.054
  4. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.052
  5. What Is Organized Screening and What Is Its Value? Gastrointest Endosc Clin N Am. 2020 Jul; 30(3):393-411.
    View in: PubMed
    Score: 0.051
  6. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5.
    View in: PubMed
    Score: 0.045
  7. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
    View in: PubMed
    Score: 0.045
  8. Colorectal Cancer Screening: Money Isn't Everything . . . But It Helps! Gastroenterology. 2017 11; 153(5):1181-1183.
    View in: PubMed
    Score: 0.043
  9. Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. Gastrointest Endosc. 2018 Mar; 87(3):755-765.e1.
    View in: PubMed
    Score: 0.042
  10. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 08 01; 318(5):483.
    View in: PubMed
    Score: 0.042
  11. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
    View in: PubMed
    Score: 0.041
  12. The Best Laid Plans: Adaptation is an Essential Part of Going From Efficacy Research to Program Implementation. Gastroenterology. 2017 03; 152(4):693-694.
    View in: PubMed
    Score: 0.041
  13. In simulation modelling, there are multiple ways to effectively screen for colorectal cancer. Evid Based Med. 2017 04; 22(2):59.
    View in: PubMed
    Score: 0.041
  14. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688.
    View in: PubMed
    Score: 0.041
  15. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
    View in: PubMed
    Score: 0.040
  16. Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
    View in: PubMed
    Score: 0.040
  17. Colorectal cancer screening: 80% by 2018. Colonoscopists simply cannot do it alone. Gastrointest Endosc. 2016 Mar; 83(3):552-4.
    View in: PubMed
    Score: 0.038
  18. Colorectal-cancer screening--coming of age. N Engl J Med. 2013 Sep 19; 369(12):1164-6.
    View in: PubMed
    Score: 0.032
  19. Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full. Gastroenterology. 2013 Jul; 145(1):39-42.
    View in: PubMed
    Score: 0.032
  20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol. 2013 Sep; 11(9):1158-66.
    View in: PubMed
    Score: 0.031
  21. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012 Sep; 143(3):844-857.
    View in: PubMed
    Score: 0.030
  22. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012 Jul; 18(7):370-8.
    View in: PubMed
    Score: 0.030
  23. The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med. 2012 Apr 09; 172(7):582-3.
    View in: PubMed
    Score: 0.029
  24. Editorial: taking FIT to the people: out of the office and into the mail. Am J Gastroenterol. 2012 Jan; 107(1):108-10.
    View in: PubMed
    Score: 0.029
  25. Optimizing colorectal cancer screening by getting FIT right. Gastroenterology. 2011 Nov; 141(5):1551-5.
    View in: PubMed
    Score: 0.028
  26. Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol. 2012 Jan; 10(1):37-45.
    View in: PubMed
    Score: 0.028
  27. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33:101-10.
    View in: PubMed
    Score: 0.028
  28. Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol. 2009 Apr; 104(4):939-41.
    View in: PubMed
    Score: 0.024
  29. Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut. 2007 Nov; 56(11):1493-4.
    View in: PubMed
    Score: 0.022
  30. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006 Dec 19; 145(12):880-6.
    View in: PubMed
    Score: 0.020
  31. Reducing unnecessary surveillance colonoscopies: a mandate for endoscopists. Gastrointest Endosc. 2006 Jan; 63(1):104-6.
    View in: PubMed
    Score: 0.019
  32. Colonoscopic screening of women for colorectal neoplasia. N Engl J Med. 2005 Aug 25; 353(8):844-6; author reply 844-6.
    View in: PubMed
    Score: 0.018
  33. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005 Jun; 54(6):807-13.
    View in: PubMed
    Score: 0.018
  34. Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer. Gut. 2005 Sep; 54(9):1273-8.
    View in: PubMed
    Score: 0.018
  35. Colonoscopy capacity: Can we build it? Will they come? Gastroenterology. 2004 Dec; 127(6):1841-4.
    View in: PubMed
    Score: 0.018
  36. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Netw Open. 2024 Jul 01; 7(7):e2421019.
    View in: PubMed
    Score: 0.017
  37. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
    View in: PubMed
    Score: 0.017
  38. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Netw Open. 2024 Apr 01; 7(4):e244611.
    View in: PubMed
    Score: 0.017
  39. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. Ann Intern Med. 2024 Apr; 177(4):542-543.
    View in: PubMed
    Score: 0.017
  40. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort. JAMA Netw Open. 2024 Apr 01; 7(4):e245295.
    View in: PubMed
    Score: 0.017
  41. Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med. 2004 Mar; 38(3):276-83.
    View in: PubMed
    Score: 0.017
  42. Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
    View in: PubMed
    Score: 0.017
  43. What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
    View in: PubMed
    Score: 0.016
  44. Transportation barriers and endoscopic procedures: barriers, legal challenges, and strategies for GI endoscopy units. Gastrointest Endosc. 2023 10; 98(4):475-481.
    View in: PubMed
    Score: 0.016
  45. Does Screening Colonoscopy Have a Future in the United States? Clin Gastroenterol Hepatol. 2023 11; 21(12):3005-3010.
    View in: PubMed
    Score: 0.016
  46. Re: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003 Jun 04; 95(11):830-1; author reply 831.
    View in: PubMed
    Score: 0.016
  47. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1.
    View in: PubMed
    Score: 0.016
  48. Does family history still matter in the era of screening colonoscopy? Clin Gastroenterol Hepatol. 2003 Mar; 1(2):69-70.
    View in: PubMed
    Score: 0.016
  49. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.015
  50. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):22-29.
    View in: PubMed
    Score: 0.015
  51. Complications of screening flexible sigmoidoscopy. Gastroenterology. 2002 Dec; 123(6):1786-92.
    View in: PubMed
    Score: 0.015
  52. Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted? Gastroenterol Clin North Am. 2002 Dec; 31(4):1015-29, vii.
    View in: PubMed
    Score: 0.015
  53. Could screening for colorectal cancer be harmful? Am J Gastroenterol. 2002 Jan; 97(1):198.
    View in: PubMed
    Score: 0.014
  54. Flexible sigmoidoscopy: an important screening option for average-risk individuals. Gastrointest Endosc Clin N Am. 2002 Jan; 12(1):23-40, vi.
    View in: PubMed
    Score: 0.014
  55. Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study. Endoscopy. 2021 Apr; 53(4):402-410.
    View in: PubMed
    Score: 0.013
  56. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020 07; 70(4):283-298.
    View in: PubMed
    Score: 0.013
  57. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer. J Med Screen. 2021 06; 28(2):140-147.
    View in: PubMed
    Score: 0.013
  58. Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population. Clin Gastroenterol Hepatol. 2020 11; 18(12):2734-2741.e6.
    View in: PubMed
    Score: 0.013
  59. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.013
  60. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
    View in: PubMed
    Score: 0.013
  61. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.012
  62. Colorectal cancer screening: new opportunities. Surg Oncol Clin N Am. 1999 Oct; 8(4):673-91, vi-vii.
    View in: PubMed
    Score: 0.012
  63. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Ann Intern Med. 2019 07 02; 171(1):19-26.
    View in: PubMed
    Score: 0.012
  64. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection. Ann Intern Med. 2019 05 21; 170(10):736-737.
    View in: PubMed
    Score: 0.012
  65. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999 May 05; 281(17):1611-7.
    View in: PubMed
    Score: 0.012
  66. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc. 2009 May; 69(6):1004-10.
    View in: PubMed
    Score: 0.012
  67. Eptifibatide in acute coronary syndromes. N Engl J Med. 1999 Jan 07; 340(1):60; author reply 61.
    View in: PubMed
    Score: 0.012
  68. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
    View in: PubMed
    Score: 0.011
  69. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 01; 89(1):168-176.e3.
    View in: PubMed
    Score: 0.011
  70. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol. 1998 Jul; 93(7):1060-3.
    View in: PubMed
    Score: 0.011
  71. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization. Am J Gastroenterol. 1998 May; 93(5):743-7.
    View in: PubMed
    Score: 0.011
  72. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8.
    View in: PubMed
    Score: 0.011
  73. Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997 Dec; 103(6):520-8.
    View in: PubMed
    Score: 0.011
  74. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017 Nov; 112(11):1728-1735.
    View in: PubMed
    Score: 0.011
  75. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017 Oct 17; 167(8):565-575.
    View in: PubMed
    Score: 0.011
  76. Importance of colonic adenomas 5 mm or less in diameter. N Engl J Med. 1997 Jun 12; 336(24):1761-2.
    View in: PubMed
    Score: 0.010
  77. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 07; 153(1):307-323.
    View in: PubMed
    Score: 0.010
  78. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul; 112(7):1016-1030.
    View in: PubMed
    Score: 0.010
  79. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017 07; 86(1):18-33.
    View in: PubMed
    Score: 0.010
  80. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-society Task Force on Colorectal Cancer. J Pediatr Gastroenterol Nutr. 2017 05; 64(5):836-843.
    View in: PubMed
    Score: 0.010
  81. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
    View in: PubMed
    Score: 0.010
  82. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 05; 112(5):682-690.
    View in: PubMed
    Score: 0.010
  83. Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017 05; 85(5):873-882.
    View in: PubMed
    Score: 0.010
  84. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 05; 152(6):1605-1614.
    View in: PubMed
    Score: 0.010
  85. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 04; 152(5):1217-1237.e3.
    View in: PubMed
    Score: 0.010
  86. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 01; 112(1):37-53.
    View in: PubMed
    Score: 0.010
  87. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointest Endosc. 2017 Jan; 85(1):2-21.e3.
    View in: PubMed
    Score: 0.010
  88. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007 Jun; 56(6):756-62.
    View in: PubMed
    Score: 0.010
  89. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
    View in: PubMed
    Score: 0.010
  90. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc. 2017 Mar; 85(3):601-610.e2.
    View in: PubMed
    Score: 0.010
  91. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):85-94.
    View in: PubMed
    Score: 0.010
  92. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 11; 31(11):1323-1330.
    View in: PubMed
    Score: 0.010
  93. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.010
  94. Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2016 Mar; 111(3):337-46; quiz 347.
    View in: PubMed
    Score: 0.010
  95. Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2016 Mar; 150(3):758-768.e11.
    View in: PubMed
    Score: 0.010
  96. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
    View in: PubMed
    Score: 0.010
  97. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
    View in: PubMed
    Score: 0.010
  98. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastrointest Endosc. 2016 Mar; 83(3):489-98.e10.
    View in: PubMed
    Score: 0.010
  99. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointest Endosc. 2016 Mar; 83(3):617-26.e2.
    View in: PubMed
    Score: 0.009
  100. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA. 2015 Jun 16; 313(23):2349-58.
    View in: PubMed
    Score: 0.009
  101. Building Data Infrastructure to Evaluate and Improve Quality: PCORnet. J Oncol Pract. 2015 May; 11(3):204-6.
    View in: PubMed
    Score: 0.009
  102. CDC Grand Rounds: the future of cancer screening. MMWR Morb Mortal Wkly Rep. 2015 Apr 03; 64(12):324-7.
    View in: PubMed
    Score: 0.009
  103. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer. 2015 Mar 14; 15:123.
    View in: PubMed
    Score: 0.009
  104. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.009
  105. Radiographic features of anterior buccal mandibular depression in modern human cadavers. Dentomaxillofac Radiol. 1995 Feb; 24(1):46-9.
    View in: PubMed
    Score: 0.009
  106. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4.
    View in: PubMed
    Score: 0.009
  107. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. Gut. 2016 Feb; 65(2):271-7.
    View in: PubMed
    Score: 0.009
  108. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.009
  109. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
    View in: PubMed
    Score: 0.009
  110. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer. Gastrointest Endosc. 2014 Oct; 80(4):543-562.
    View in: PubMed
    Score: 0.009
  111. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology. 2014 Oct; 147(4):903-24.
    View in: PubMed
    Score: 0.009
  112. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014 Oct; 109(10):1528-45.
    View in: PubMed
    Score: 0.009
  113. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
    View in: PubMed
    Score: 0.009
  114. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014 Aug; 57(8):1025-48.
    View in: PubMed
    Score: 0.009
  115. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2014 Aug; 80(2):197-220.
    View in: PubMed
    Score: 0.009
  116. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014 Aug; 147(2):502-26.
    View in: PubMed
    Score: 0.009
  117. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014 Aug; 109(8):1159-79.
    View in: PubMed
    Score: 0.009
  118. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 06 26; 370(26):2541.
    View in: PubMed
    Score: 0.009
  119. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.008
  120. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 03; 370(14):1298-306.
    View in: PubMed
    Score: 0.008
  121. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03; 370(14):1287-97.
    View in: PubMed
    Score: 0.008
  122. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
    View in: PubMed
    Score: 0.008
  123. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep; 125(3):668-76.
    View in: PubMed
    Score: 0.008
  124. Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013 Jun; 103(6):1128-33.
    View in: PubMed
    Score: 0.008
  125. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.008
  126. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol. 2013 Mar; 11(3):204-7.
    View in: PubMed
    Score: 0.008
  127. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
    View in: PubMed
    Score: 0.008
  128. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
    View in: PubMed
    Score: 0.008
  129. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9.
    View in: PubMed
    Score: 0.007
  130. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc. 2011 Mar; 73(3):419-22.
    View in: PubMed
    Score: 0.007
  131. Lack of association between insulin sensitivity and colorectal adenoma risk. Nutr Cancer. 2011; 63(1):6-11.
    View in: PubMed
    Score: 0.007
  132. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.007
  133. Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):42-48.e1.
    View in: PubMed
    Score: 0.006
  134. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
    View in: PubMed
    Score: 0.006
  135. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.006
  136. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
    View in: PubMed
    Score: 0.006
  137. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 07; 149(7):441-50, W81.
    View in: PubMed
    Score: 0.006
  138. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.006
  139. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
    View in: PubMed
    Score: 0.006
  140. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.006
  141. Implications of new colorectal cancer screening technologies for primary care practice. Med Care. 2008 Sep; 46(9 Suppl 1):S138-46.
    View in: PubMed
    Score: 0.006
  142. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
    View in: PubMed
    Score: 0.006
  143. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.006
  144. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 May-Jun; 58(3):130-60.
    View in: PubMed
    Score: 0.006
  145. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008 May; 134(5):1570-95.
    View in: PubMed
    Score: 0.005
  146. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
    View in: PubMed
    Score: 0.005
  147. Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study. Drug Saf. 2008; 31(4):325-34.
    View in: PubMed
    Score: 0.005
  148. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.005
  149. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.005
  150. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
    View in: PubMed
    Score: 0.005
  151. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007 May; 65(6):757-66.
    View in: PubMed
    Score: 0.005
  152. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.005
  153. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis. 2007 Aug; 28(8):1672-9.
    View in: PubMed
    Score: 0.005
  154. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):526-31.
    View in: PubMed
    Score: 0.005
  155. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer. 2007 Feb 01; 120(3):656-63.
    View in: PubMed
    Score: 0.005
  156. Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia. Clin Chem. 2006 Dec; 52(12):2299-302.
    View in: PubMed
    Score: 0.005
  157. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol. 2006 Jul; 4(7):894-901.
    View in: PubMed
    Score: 0.005
  158. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.005
  159. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006 May; 130(6):1865-71.
    View in: PubMed
    Score: 0.005
  160. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006 May; 130(6):1872-85.
    View in: PubMed
    Score: 0.005
  161. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006 May-Jun; 56(3):143-59; quiz 184-5.
    View in: PubMed
    Score: 0.005
  162. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin. 2006 May-Jun; 56(3):160-7; quiz 185-6.
    View in: PubMed
    Score: 0.005
  163. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control. 2006 Apr; 17(3):239-49.
    View in: PubMed
    Score: 0.005
  164. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005 Sep; 129(3):837-45.
    View in: PubMed
    Score: 0.005
  165. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005 Jul 15; 65(14):6063-9.
    View in: PubMed
    Score: 0.005
  166. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis. 2005 Aug; 26(8):1422-9.
    View in: PubMed
    Score: 0.004
  167. CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol. 2004 Nov 01; 160(9):842-52.
    View in: PubMed
    Score: 0.004
  168. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology. 2004 Sep; 127(3):714-22.
    View in: PubMed
    Score: 0.004
  169. The evolution to stool DNA testing for colorectal cancer. Aliment Pharmacol Ther. 2004 Jun 15; 19(12):1225-33.
    View in: PubMed
    Score: 0.004
  170. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 2004 May; 39(5):1204-12.
    View in: PubMed
    Score: 0.004
  171. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):538-45.
    View in: PubMed
    Score: 0.004
  172. Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003 Nov; 14(9):879-87.
    View in: PubMed
    Score: 0.004
  173. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Arch Intern Med. 2003 May 26; 163(10):1165-71.
    View in: PubMed
    Score: 0.004
  174. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003 Feb; 124(2):544-60.
    View in: PubMed
    Score: 0.004
  175. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002 Jun; 97(6):1296-308.
    View in: PubMed
    Score: 0.004
  176. Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
    View in: PubMed
    Score: 0.004
  177. Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology. 2002 Apr; 122(4):940-7.
    View in: PubMed
    Score: 0.004
  178. Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol. 2002 Mar; 55(3):310-3.
    View in: PubMed
    Score: 0.004
  179. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.004
  180. [Search for microsatellite instability in colorectal cancer: an effective way to detect HNPCC?]. Gastroenterol Clin Biol. 2001 Oct; 25(10):929-31.
    View in: PubMed
    Score: 0.004
  181. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol. 2001 Feb; 96(2):338-47.
    View in: PubMed
    Score: 0.003
  182. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology. 2001 Jan; 120(1):21-30.
    View in: PubMed
    Score: 0.003
  183. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000 May; 27(4):623-30.
    View in: PubMed
    Score: 0.003
  184. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000 Mar; 95(3):788-92.
    View in: PubMed
    Score: 0.003
  185. Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries. Catheter Cardiovasc Interv. 2000 Feb; 49(2):121-6.
    View in: PubMed
    Score: 0.003
  186. Cardiac exposure history as a determinant of symptoms and emergency department utilization in noncardiac chest pain patients. J Behav Med. 1999 Dec; 22(6):605-17.
    View in: PubMed
    Score: 0.003
  187. Spontaneous peritonitis caused by Streptococcus bovis. J Clin Gastroenterol. 1994 Dec; 19(4):346.
    View in: PubMed
    Score: 0.002
  188. Risk reduction: attitudes and behavior of family practice residents. Fam Med. 1988 Mar-Apr; 20(2):108-11.
    View in: PubMed
    Score: 0.001
  189. Malignant fibrous histiocytoma arising in a scar. Eur J Surg Oncol. 1988 Feb; 14(1):83-6.
    View in: PubMed
    Score: 0.001

© 2024 Kaiser Permanente